UO
UOKAF
MDJM LTD
$0.4200
+5.26%
No data for this timeframe.
Vol
SEC Reports6
Exchange OTC·Sector Real Estate Agents & Managers (For Others)·Inc. E9·CIK 0001741534·Prev Close $0.3990
Recent Activity
Jun 11, 2026
SEC
MDJM LTD closed the previously announced acquisition of a 75% equity interest in Mirai Co., Ltd., a Japanese company, an
6-K — Impact 4/10
May 27, 2026
SEC
MDJM LTD disclosed the resignation of its auditor RBSM LLP effective May 21, 2026, and the immediate engagement of Tang
6-K — Impact 7/10
May 20, 2026
SEC
MDJM LTD announced a share purchase agreement to acquire a 75% controlling stake in Mirai Co., Ltd., a Japan-based suppl
6-K — Impact 7/10
Latest Reports
NEUTRAL
6-K
4/10
MDJM LTD closed the previously announced acquisition of a 75% equity interest in Mirai Co., Ltd., a Japanese company, an
Jun 11, 2026
BEARISH
6-K
7/10
MDJM LTD disclosed the resignation of its auditor RBSM LLP effective May 21, 2026, and the immediate engagement of Tang
May 27, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 1 mixed, 2 neutral. Avg impact: 6.0/10.
NEUTRAL
6-K
4/10
MDJM LTD closed the previously announced acquisition of a 75% equity interest in Mirai Co., Ltd., a
Jun 11, 2026
BEARISH
6-K
7/10
MDJM LTD disclosed the resignation of its auditor RBSM LLP effective May 21, 2026, and the immediate
May 27, 2026
BULLISH
6-K
7/10
MDJM LTD announced a share purchase agreement to acquire a 75% controlling stake in Mirai Co., Ltd.,
May 20, 2026
MIXED
6-K
7/10
MDJM LTD's wholly-owned subsidiary entered into a Share Purchase Agreement to acquire 75% of Mirai C
May 6, 2026
NEUTRAL
6-K
3/10
MDJM LTD adopted a 2026 Equity Incentive Plan and immediately issued 200,000 Class B ordinary shares
May 4, 2026
BEARISH
6-K
8/10
MDJM LTD shareholders approved a massive increase in authorized share capital and granted the board
Apr 22, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.